Bile secretion machinery

The bile secretion machinery refers to a complex integrated system of transmembrane transporters, enzymes, and regulatory nuclear receptors located primarily in hepatocytes and cholangiocytes that facilitate the production and flow of bile. Key components include apical efflux pumps such as the Bile Salt Export Pump (BSEP/ABCB11), Multidrug Resistance Protein 3 (MDR3/ABCB4), and Multidrug Resistance-associated Protein 2 (MRP2/ABCC2), as well as basolateral uptake transporters like the Sodium-taurocholate Cotransporting Polypeptide (NTCP/SLC10A1). This machinery is essential for the elimination of endogenous waste products like bilirubin and cholesterol, the intestinal absorption of dietary lipids, and the detoxification of xenobiotics. Dysregulation or genetic mutations in these components lead to cholestatic liver diseases, characterized by the accumulation of toxic bile acids and subsequent liver damage. Pharmacological intervention often targets the regulatory Farnesoid X Receptor (FXR) to modulate the expression of these transporters or inhibits the Apical Sodium-dependent Bile acid Transporter (ASBT) to reduce the bile acid pool, though inhibition of efflux components like BSEP is a major cause of drug-induced liver injury.

Other names

Hepatobiliary transport systemBile acid transport systemBile secretory apparatusHepatocyte apical and basolateral transporters

Drugs targeting this machinery typically act as agonists of regulatory nuclear receptors (e.g., FXR), inhibitors of bile acid reabsorption (e.g., ASBT inhibitors), or competitive inhibitors of specific efflux transporters (e.g., BSEP inhibitors causing toxicity).